Overcoming drug resistance in advanced prostate cancer by drug repurposing

HF Bahmad, T Demus, MM Moubarak, D Daher… - Medical …, 2022 - mdpi.com
Prostate cancer (PCa) is the second most common cancer in men. Common treatments
include active surveillance, surgery, or radiation. Androgen deprivation therapy and …

Robot-assisted radical prostatectomy: inching toward gold standard

A Sood, W Jeong, JO Peabody, AK Hemal… - Urologic …, 2014 - urologic.theclinics.com
Prostate cancer (PCa) remains the most common internal organ malignancy and the second
leading cause of cancer-related death in men in the United States. 1 Most cases of PCa are …

Prostate cancer, version 2.2014

JL Mohler, PW Kantoff, AJ Armstrong… - Journal of the National …, 2014 - jnccn.org
Prostate cancer has surpassed lung cancer as the most common cancer in men in the
United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary …

More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer

F Abdollah, G Gandaglia, N Suardi, U Capitanio… - European urology, 2015 - Elsevier
Background The role of extended pelvic lymph node dissection (ePLND) in treating prostate
cancer (PCa) patients with lymph node invasion (LNI) remains controversial. Objective The …

Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era

G Gandaglia, JD Sammon, SL Chang… - Journal of Clinical …, 2014 - ascopubs.org
Purpose Given the lack of randomized trials comparing robot-assisted radical prostatectomy
(RARP) and open radical prostatectomy (ORP), we sought to re-examine the outcomes of …

Cancer screening rates in individuals with different life expectancies

TJ Royce, LH Hendrix, WA Stokes, IM Allen… - JAMA internal …, 2014 - jamanetwork.com
Importance Routine cancer screening has unproven net benefit for patients with limited life
expectancy. Objective To examine the patterns of prostate, breast, cervical, and colorectal …

Temporal trends and the impact of race, insurance, and socioeconomic status in the management of localized prostate cancer

PJ Gray, CC Lin, MR Cooperberg, A Jemal… - European urology, 2017 - Elsevier
Background Numerous management options exist for patients with prostate cancer;
however, recent trends and their influencing factors are not well described. Objective To …

Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control

JC Hu, G Gandaglia, PI Karakiewicz, PL Nguyen… - European urology, 2014 - Elsevier
Background Robot-assisted radical prostatectomy (RARP) remains controversial, and no
improvement in cancer control outcomes has been demonstrated over open radical …

The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base

JM Martin, EA Handorf, A Kutikov, RG Uzzo… - Cancer, 2014 - Wiley Online Library
BACKGROUND Brachytherapy has been shown to be an efficacious and cost‐effective
treatment among patients with localized prostate cancer. In this study, the authors examined …

Robot-assisted radical prostatectomy and extended pelvic lymph node dissection in patients with locally-advanced prostate cancer

G Gandaglia, E De Lorenzis, G Novara, N Fossati… - European urology, 2017 - Elsevier
Background Limited data are available on the role of robot-assisted radical prostatectomy
(RARP) in patients with locally advanced prostate cancer (PCa). Objective To describe our …